PharmiWeb.com - Global Pharma News & Resources

Reports - Press Releases

Date Title Company
25-Nov-2024 Doron Therapeutics Raises $11M Series A to Progress Biologic Regenerative Osteoarthritis Drug into Phase 3 Clinical Studies AccessWire
25-Nov-2024 Acreage Provides Update on Corporate Transactions AccessWire
25-Nov-2024 Quantum BioPharma Previously Known as FSD Pharma (Nasdaq:HUGE) (CSE:HUGE) Invites Shareholders to Come Forward and Join Hands With the Company in the US700M$+ Court Case the Company Has Filed Against CIBC, RBC, and Others for Alleged Spoofing/Stock Price Manipulation AccessWire
25-Nov-2024 Moderna to Present at Upcoming Conferences in December 2024 AccessWire
25-Nov-2024 BioNxt Announces Enhanced Sublingual Product Development Pipeline with Innovative Solutions for Autoimmune Diseases and Longevity AccessWire
22-Nov-2024 Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment AccessWire
22-Nov-2024 Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM) AccessWire
22-Nov-2024 Laurel Bridge Software Advances Medical Imaging Workflow With New AI and Cloud Innovations at RSNA 2024 AccessWire
22-Nov-2024 Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs AccessWire
22-Nov-2024 Hemogenyx Pharmaceuticals PLC Announces Notice of Extraordinary General Meeting AccessWire
22-Nov-2024 Aptevo Highlights the Potential of the Company's Robust Portfolio in Cancer Immunotherapy, the Success of Bispecifics as a Category, and Their Growing Importance in the Oncology Treatment Paradigm AccessWire
22-Nov-2024 Frequency Exchange Welcomes Former NHL Star and Current President of the Boston Bruins Cam Neely to Its Advisory Board AccessWire
22-Nov-2024 Sunshine Biopharma Launches a New Generic Prescription Drug AccessWire
22-Nov-2024 Protagonist Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference 2024 AccessWire
22-Nov-2024 Hemogenyx Pharmaceuticals PLC Announces IRB Approval for Phase I Clinical Trial AccessWire
22-Nov-2024 Modular Medical Announces Pricing of $8.2 Million Public Offering AccessWire
22-Nov-2024 Nicole Garrett and Under Pressure Hyperbarics Lead the Charge in Wellness Education With Immersive Events at L.A. Fashion Weekend and Beyond AccessWire
21-Nov-2024 Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States AccessWire
21-Nov-2024 Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States AccessWire
21-Nov-2024 Modular Medical Announces Proposed Public Offering AccessWire